Literature DB >> 6846068

Selenium therapy of myotonic dystrophy.

G Orndahl, A Rindby, E Selin.   

Abstract

A patient with myotonic dystrophy (MD) has been treated for two years with selenium and vitamin E. The serum selenium concentration and other relevant variables were continuously studied. The patient showed a marked subjective and objective improvement with increased muscular strength and regression of pathological electromyographic findings. To our knowledge, this is the first report of successful treatment of MD.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6846068     DOI： 10.1111/j.0954-6820.1983.tb03725.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


  5 in total

Review 1.  Determination of selenium in blood components by X-ray emission spectrometry. Procedures, concentration levels, and health implications.

Authors:  H Robberecht; H Deelstra; R Van Grieken
Journal:  Biol Trace Elem Res       Date:  1990-06       Impact factor: 3.738

2.  Thyroid function and plasma selenium in chronic uremic patients on hemodialysis treatment.

Authors:  G Napolitano; M Bonomini; G Bomba; I Bucci; V Todisco; A Albertazzi; F Monaco
Journal:  Biol Trace Elem Res       Date:  1996-12       Impact factor: 3.738

3.  Free radicals, lipid peroxides and antioxidants in blood of patients with myotonic dystrophy.

Authors:  Y Ihara; A Mori; T Hayabara; R Namba; K Nobukuni; K Sato; S Miyata; R Edamatsu; J Liu; M Kawai
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 4.  Understanding the importance of selenium and selenoproteins in muscle function.

Authors:  M Rederstorff; A Krol; A Lescure
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

5.  Vitamin E deficiency in rabbits receiving a high PUFA diet with and without a non-absorbable antioxidant. 1. Incorporation of [1-14C]glycine into skeletal muscle proteins.

Authors:  J F Diehl
Journal:  Z Ernahrungswiss       Date:  1986-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.